Skip to main content
SpringerLink
Log in

The Swedish SCOPA-SLEEP for assessment of sleep disorders in Parkinson’s disease and healthy controls

  • Brief Communication
  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Purpose

SCOPA-SLEEP is a rating scale for night-time sleep and daytime sleepiness (DS) proposed for use among people with Parkinson’s disease (PD) as well as others. We translated it into Swedish and assessed its psychometric properties in PD and age-matched healthy controls.

Methods

Following translation according to the dual-panel approach, the Swedish SCOPA-SLEEP was field-tested regarding comprehensibility, relevance and respondent burden (n = 20). It was then psychometrically tested according to classical test theory (data completeness, scaling assumptions, targeting, reliability and construct validity) using data from 149 people with PD and 53 age-matched healthy controls from the prospective Swedish BioFINDER study.

Results

SCOPA-SLEEP took a mean of 3.5 min to complete and was considered easy to use and relevant. Missing item responses were <8 %, corrected item–total correlations were ≥0.47 (except for one DS item among controls), factor analyses suggested one dimension per scale, floor/ceiling effects were ≤17 %, reliability was ≥0.85 except for the DS scale among controls (0.65) and construct validity was supported.

Conclusions

Observations concur with previous evaluations, thus providing initial support for the Swedish SCOPA-SLEEP among people with PD. Further studies are needed to establish its generic properties and to understand its measurement properties in better detail.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Schrempf, W., Brandt, M. D., Storch, A., & Reichmann, H. (2014). Sleep disorders in Parkinson’s disease. Journal of Parkinson’s Disease, 4(2), 211–221.

    PubMed  Google Scholar 

  2. Videnovic, A., & Golombek, D. (2013). Circadian and sleep disorders in Parkinson’s disease. Experimental Neurology, 243, 45–56.

    Article  PubMed  Google Scholar 

  3. Hogl, B., Arnulf, I., Comella, C., Ferreira, J., Iranzo, A., Tilley, B., et al. (2010). Scales to assess sleep impairment in Parkinson’s disease: Critique and recommendations. Movement Disorders, 25(16), 2704–2716.

    Article  PubMed  Google Scholar 

  4. Marinus, J., Visser, M., van Hilten, J. J., Lammers, G. J., & Stiggelbout, A. M. (2003). Assessment of sleep and sleepiness in Parkinson disease. Sleep, 26(8), 1049–1054.

    PubMed  Google Scholar 

  5. Martinez-Martin, P., Visser, M., Rodriguez-Blazquez, C., Marinus, J., Chaudhuri, K. R., van Hilten, J. J., et al. (2008). SCOPA-sleep and PDSS: Two scales for assessment of sleep disorder in Parkinson’s disease. Movement Disorders, 23(12), 1681–1688.

    Article  PubMed  Google Scholar 

  6. Setthawatcharawanich, S., Limapichat, K., Sathirapanya, P., & Phabphal, K. (2011). Validation of the Thai SCOPA-sleep scale for assessment of sleep and sleepiness in patients with Parkinson’s disease. Journal of the Medical Association of Thailand, 94(2), 179–184.

    PubMed  Google Scholar 

  7. Swaine-Verdier, A., Doward, L. C., Hagell, P., Thorsen, H., & McKenna, S. P. (2004). Adapting quality of life instruments. Value Health, 7(Suppl 1), S27–S30.

    Article  PubMed  Google Scholar 

  8. Gelb, D. J., Oliver, E., & Gilman, S. (1999). Diagnostic criteria for Parkinson disease. Archives of Neurology, 56(1), 33–39.

    Article  CAS  PubMed  Google Scholar 

  9. Fahn, S., Elton, R. L., & Members of the UPDRS Development Committee. (1987). Unified Parkinson’s Disease Rating Scale. In S. Fahn, C. D. Marsden, D. B. Calne, & M. Goldstein (Eds.), Recent developments in Parkinson’s Disease (Vol. 2, pp. 153–163). Florham Park: MacMillan Healthcare Information.

    Google Scholar 

  10. Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.

    Article  CAS  PubMed  Google Scholar 

  11. Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression and mortality. Neurology, 17(5), 427–442.

    Article  CAS  PubMed  Google Scholar 

  12. Lorenzo-Seva, U., & Ferrando, P. J. (2006). FACTOR: A computer program to fit the exploratory factor analysis model. Behavior Research Methods, 38(1), 88–91.

    Article  PubMed  Google Scholar 

  13. Hobart, J., & Cano, S. (2009). Improving the evaluation of therapeutic interventions in multiple sclerosis: The role of new psychometric methods. Health Technol Assess, 13(12), iii, ix-x, 1–177.

  14. Ware, J. E, Jr, & Gandek, B. (1998). Methods for testing data quality, scaling assumptions, and reliability: The IQOLA Project approach. International Quality of Life Assessment. Journal of Clinical Epidemiology, 51(11), 945–952.

    Article  PubMed  Google Scholar 

  15. Saris-Baglama, R. N., Dewey, C. J., Chisholm, G. B., Kosinski, M., Bjorner, J. B., & Ware, J. E, Jr. (2004). SF health outcomes™ scoring software user’s guide. Lincoln: QualityMetric Inc.

    Google Scholar 

  16. Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory (3rd ed.). New York: McGraw-Hill Inc.

    Google Scholar 

  17. Timmerman, M. E., & Lorenzo-Seva, U. (2011). Dimensionality assessment of ordered polytomous items with parallel analysis. Psychological Methods, 16(2), 209–220.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors wish to thank the participants, translators and lay people for their cooperation, and S. Hall, Y. Surova, K. Johansson, J. Reimer and A. Höglund for data collection. The study was supported by the European Research Council, the Swedish Research Council, the Swedish Parkinson Foundation, the Swedish Parkinson Academy, the Basal Ganglia Disorders Linnaeus Consortium (BAGADILICO) at Lund University, the Swedish federal government under the ALF agreement, and Kristianstad University, Kristianstad, Sweden. The funding sources had no role in the design and conduct of the study; in the collection, analysis, interpretation of the data; or in the preparation, review, or approval of the manuscript.

Author information

Authors and Affiliations

  1. The PRO-CARE Group, School of Health and Society, Kristianstad University, 291 88, Kristianstad, Sweden

    Peter Hagell & Albert Westergren

  2. Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden

    Shorena Janelidze & Oskar Hansson

  3. Memory Clinic, Skåne University Hospital, Malmö, Sweden

    Oskar Hansson

Authors
  1. Peter Hagell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Albert Westergren
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shorena Janelidze
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oskar Hansson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Hagell.

Ethics declarations

Conflict of interest

None.

Appendix

Appendix

See Table 3.

Table 3 Item and response category wording of the SCOPA-SLEEP, English and Swedish versions
Full size table

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hagell, P., Westergren, A., Janelidze, S. et al. The Swedish SCOPA-SLEEP for assessment of sleep disorders in Parkinson’s disease and healthy controls. Qual Life Res 25, 2571–2577 (2016). https://doi.org/10.1007/s11136-016-1318-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-016-1318-2

Keywords

Search

Navigation